

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | angiotensin maturation (GO:0002003) | 5.75736352 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.65002834 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.65002834 |
| 4 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.54740381 |
| 5 | high-density lipoprotein particle remodeling (GO:0034375) | 5.41957022 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.38026502 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 5.38026502 |
| 8 | protein carboxylation (GO:0018214) | 5.15359813 |
| 9 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.15359813 |
| 10 | sulfur amino acid catabolic process (GO:0000098) | 5.12918035 |
| 11 | aromatic amino acid family catabolic process (GO:0009074) | 5.06180656 |
| 12 | complement activation, alternative pathway (GO:0006957) | 5.02484628 |
| 13 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.97325077 |
| 14 | reverse cholesterol transport (GO:0043691) | 4.88026988 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 4.87387903 |
| 16 | intestinal absorption (GO:0050892) | 4.80312944 |
| 17 | negative regulation of fibrinolysis (GO:0051918) | 4.72465244 |
| 18 | regulation of protein activation cascade (GO:2000257) | 4.68864935 |
| 19 | urea metabolic process (GO:0019627) | 4.64306324 |
| 20 | urea cycle (GO:0000050) | 4.64306324 |
| 21 | tryptophan catabolic process (GO:0006569) | 4.56715397 |
| 22 | indole-containing compound catabolic process (GO:0042436) | 4.56715397 |
| 23 | indolalkylamine catabolic process (GO:0046218) | 4.56715397 |
| 24 | phospholipid efflux (GO:0033700) | 4.54767830 |
| 25 | bile acid biosynthetic process (GO:0006699) | 4.53096281 |
| 26 | regulation of complement activation (GO:0030449) | 4.51172361 |
| 27 | kynurenine metabolic process (GO:0070189) | 4.45731581 |
| 28 | plasma lipoprotein particle remodeling (GO:0034369) | 4.41412087 |
| 29 | protein-lipid complex remodeling (GO:0034368) | 4.41412087 |
| 30 | macromolecular complex remodeling (GO:0034367) | 4.41412087 |
| 31 | cysteine metabolic process (GO:0006534) | 4.40125765 |
| 32 | regulation of cholesterol esterification (GO:0010872) | 4.39877697 |
| 33 | regulation of fibrinolysis (GO:0051917) | 4.38296501 |
| 34 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.36000703 |
| 35 | glyoxylate metabolic process (GO:0046487) | 4.34653970 |
| 36 | lipoprotein transport (GO:0042953) | 4.32570124 |
| 37 | regulation of triglyceride catabolic process (GO:0010896) | 4.31255667 |
| 38 | glucocorticoid biosynthetic process (GO:0006704) | 4.29682458 |
| 39 | tryptophan metabolic process (GO:0006568) | 4.29344816 |
| 40 | phospholipid homeostasis (GO:0055091) | 4.29025236 |
| 41 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.25204575 |
| 42 | homocysteine metabolic process (GO:0050667) | 4.22025341 |
| 43 | nitrogen cycle metabolic process (GO:0071941) | 4.21570935 |
| 44 | bile acid and bile salt transport (GO:0015721) | 4.14428742 |
| 45 | negative regulation of cholesterol transport (GO:0032375) | 4.12860169 |
| 46 | negative regulation of sterol transport (GO:0032372) | 4.12860169 |
| 47 | NADH metabolic process (GO:0006734) | 4.09359145 |
| 48 | bile acid metabolic process (GO:0008206) | 4.07733497 |
| 49 | drug catabolic process (GO:0042737) | 4.07455319 |
| 50 | cellular glucuronidation (GO:0052695) | 4.03125313 |
| 51 | cholesterol efflux (GO:0033344) | 3.98428291 |
| 52 | progesterone metabolic process (GO:0042448) | 3.97837952 |
| 53 | plasma lipoprotein particle clearance (GO:0034381) | 3.94526291 |
| 54 | flavonoid metabolic process (GO:0009812) | 3.85482217 |
| 55 | drug metabolic process (GO:0017144) | 3.85206255 |
| 56 | plasma lipoprotein particle assembly (GO:0034377) | 3.81505739 |
| 57 | ethanol oxidation (GO:0006069) | 3.79420105 |
| 58 | response to nitrosative stress (GO:0051409) | 3.78852114 |
| 59 | amino-acid betaine metabolic process (GO:0006577) | 3.72570654 |
| 60 | regulation of guanylate cyclase activity (GO:0031282) | 3.70803627 |
| 61 | epoxygenase P450 pathway (GO:0019373) | 3.69809396 |
| 62 | acylglycerol homeostasis (GO:0055090) | 3.66266518 |
| 63 | triglyceride homeostasis (GO:0070328) | 3.66266518 |
| 64 | renal system process involved in regulation of blood volume (GO:0001977) | 3.64154908 |
| 65 | exogenous drug catabolic process (GO:0042738) | 3.63655370 |
| 66 | benzene-containing compound metabolic process (GO:0042537) | 3.63427041 |
| 67 | uronic acid metabolic process (GO:0006063) | 3.59875032 |
| 68 | glucuronate metabolic process (GO:0019585) | 3.59875032 |
| 69 | cholesterol homeostasis (GO:0042632) | 3.59173407 |
| 70 | surfactant homeostasis (GO:0043129) | 3.57895711 |
| 71 | desmosome organization (GO:0002934) | 3.57817488 |
| 72 | serine family amino acid catabolic process (GO:0009071) | 3.57732695 |
| 73 | lysine catabolic process (GO:0006554) | 3.57595109 |
| 74 | lysine metabolic process (GO:0006553) | 3.57595109 |
| 75 | xenobiotic catabolic process (GO:0042178) | 3.56000914 |
| 76 | plasma lipoprotein particle organization (GO:0071827) | 3.54984680 |
| 77 | aromatic amino acid family metabolic process (GO:0009072) | 3.54330090 |
| 78 | sterol homeostasis (GO:0055092) | 3.52750575 |
| 79 | protein-lipid complex assembly (GO:0065005) | 3.51587295 |
| 80 | tyrosine metabolic process (GO:0006570) | 3.51299124 |
| 81 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.48499138 |
| 82 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.48499138 |
| 83 | negative regulation of lipase activity (GO:0060192) | 3.48405734 |
| 84 | low-density lipoprotein particle remodeling (GO:0034374) | 3.46736256 |
| 85 | cellular ketone body metabolic process (GO:0046950) | 3.45370032 |
| 86 | complement activation (GO:0006956) | 3.45074959 |
| 87 | complement activation, classical pathway (GO:0006958) | 3.44934229 |
| 88 | peptide catabolic process (GO:0043171) | 3.43991052 |
| 89 | regulation of cholesterol homeostasis (GO:2000188) | 3.42134786 |
| 90 | protein-lipid complex subunit organization (GO:0071825) | 3.39323717 |
| 91 | response to phenylpropanoid (GO:0080184) | 3.38342791 |
| 92 | positive regulation of lipid catabolic process (GO:0050996) | 3.37653503 |
| 93 | protein activation cascade (GO:0072376) | 3.35742015 |
| 94 | fibrinolysis (GO:0042730) | 3.35058862 |
| 95 | hormone catabolic process (GO:0042447) | 3.34664381 |
| 96 | citrulline biosynthetic process (GO:0019240) | 3.34486340 |
| 97 | alpha-amino acid catabolic process (GO:1901606) | 3.34277400 |
| 98 | regulation of bile acid biosynthetic process (GO:0070857) | 3.27386047 |
| 99 | androgen biosynthetic process (GO:0006702) | 3.26552166 |
| 100 | cellular modified amino acid catabolic process (GO:0042219) | 3.25279456 |
| 101 | lipoprotein metabolic process (GO:0042157) | 3.21906448 |
| 102 | glucocorticoid metabolic process (GO:0008211) | 3.20397329 |
| 103 | intestinal cholesterol absorption (GO:0030299) | 3.19133092 |
| 104 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.18440893 |
| 105 | cellular amino acid catabolic process (GO:0009063) | 3.18148024 |
| 106 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.17884832 |
| 107 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.16012282 |
| 108 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.14422195 |
| 109 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.14288382 |
| 110 | endocrine process (GO:0050886) | 3.14288382 |
| 111 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.14288382 |
| 112 | amine catabolic process (GO:0009310) | 3.10865203 |
| 113 | cellular biogenic amine catabolic process (GO:0042402) | 3.10865203 |
| 114 | ethanol metabolic process (GO:0006067) | 3.09033374 |
| 115 | indolalkylamine metabolic process (GO:0006586) | 3.09000095 |
| 116 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.08501408 |
| 117 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.08501408 |
| 118 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.08187074 |
| 119 | opsonization (GO:0008228) | 3.07306762 |
| 120 | regulation of cellular extravasation (GO:0002691) | 3.06740493 |
| 121 | drug transmembrane transport (GO:0006855) | 3.06681200 |
| 122 | cholesterol transport (GO:0030301) | 3.06182830 |
| 123 | sterol transport (GO:0015918) | 3.06182830 |
| 124 | cGMP-mediated signaling (GO:0019934) | 3.05893995 |
| 125 | regulation of cholesterol metabolic process (GO:0090181) | 3.05877902 |
| 126 | omega-hydroxylase P450 pathway (GO:0097267) | 3.03221810 |
| 127 | vitamin transmembrane transport (GO:0035461) | 2.97301239 |
| 128 | xenobiotic metabolic process (GO:0006805) | 2.95114929 |
| 129 | C21-steroid hormone metabolic process (GO:0008207) | 2.94466188 |
| 130 | diacylglycerol metabolic process (GO:0046339) | 2.92315424 |
| 131 | primary alcohol catabolic process (GO:0034310) | 2.90940915 |
| 132 | drug transport (GO:0015893) | 2.88110095 |
| 133 | androgen metabolic process (GO:0008209) | 2.86553402 |
| 134 | vitamin D metabolic process (GO:0042359) | 2.85859921 |
| 135 | glycosphingolipid catabolic process (GO:0046479) | 2.81182350 |
| 136 | fructose metabolic process (GO:0006000) | 2.80841114 |
| 137 | phenylpropanoid metabolic process (GO:0009698) | 2.80303180 |
| 138 | multicellular organismal water homeostasis (GO:0050891) | 2.79950039 |
| 139 | primary alcohol metabolic process (GO:0034308) | 2.78307439 |
| 140 | endothelium development (GO:0003158) | 2.74237262 |
| 141 | alkaloid metabolic process (GO:0009820) | 2.73427711 |
| 142 | C21-steroid hormone biosynthetic process (GO:0006700) | 2.71153795 |
| 143 | glycolipid catabolic process (GO:0019377) | 2.70732813 |
| 144 | glycoside metabolic process (GO:0016137) | 2.69832793 |
| 145 | positive regulation of pseudopodium assembly (GO:0031274) | 2.68323914 |
| 146 | * cyclooxygenase pathway (GO:0019371) | 2.68257823 |
| 147 | negative regulation of blood coagulation (GO:0030195) | 2.67418891 |
| 148 | negative regulation of hemostasis (GO:1900047) | 2.67418891 |
| 149 | embryonic process involved in female pregnancy (GO:0060136) | 2.66570723 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.00201658 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.44984384 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.70613915 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.30772229 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.99656320 |
| 6 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.76601336 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.95488990 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.75381682 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.30829382 |
| 10 | GATA1_22025678_ChIP-Seq_K562_Human | 2.95298586 |
| 11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.81195751 |
| 12 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.72582533 |
| 13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.44167822 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.06609297 |
| 15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.87155133 |
| 16 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.86884666 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.76340702 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.72777778 |
| 19 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.68836669 |
| 20 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.67508024 |
| 21 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.65138514 |
| 22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.64074959 |
| 23 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.63273990 |
| 24 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.61189495 |
| 25 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.60640921 |
| 26 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.60091502 |
| 27 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.54428264 |
| 28 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.52780778 |
| 29 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.50673944 |
| 30 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.48421192 |
| 31 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.48394827 |
| 32 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.46702979 |
| 33 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.46276480 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.46226645 |
| 35 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.45006200 |
| 36 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.44301806 |
| 37 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.41966215 |
| 38 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.40491031 |
| 39 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.39085388 |
| 40 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.38670054 |
| 41 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.37620454 |
| 42 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.32170703 |
| 43 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.31792826 |
| 44 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.25034995 |
| 45 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.24706671 |
| 46 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.23030499 |
| 47 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.22309672 |
| 48 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.19553580 |
| 49 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.19463925 |
| 50 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.17589551 |
| 51 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.17126578 |
| 52 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.16358312 |
| 53 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.15109084 |
| 54 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.14894589 |
| 55 | * PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.14476453 |
| 56 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.12814644 |
| 57 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.12480393 |
| 58 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.12043369 |
| 59 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.11707670 |
| 60 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.09950767 |
| 61 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.09950767 |
| 62 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.07076480 |
| 63 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05307616 |
| 64 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.04526551 |
| 65 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.03516043 |
| 66 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.98209915 |
| 67 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.97982082 |
| 68 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97645489 |
| 69 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.95304776 |
| 70 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.93856797 |
| 71 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.93125798 |
| 72 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.91932038 |
| 73 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.90732397 |
| 74 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.89004611 |
| 75 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.88007913 |
| 76 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87664178 |
| 77 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.87403009 |
| 78 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.86801589 |
| 79 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.86801589 |
| 80 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.86583005 |
| 81 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.85495163 |
| 82 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.83808434 |
| 83 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.83036932 |
| 84 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.82996600 |
| 85 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.81759905 |
| 86 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.80927451 |
| 87 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80502341 |
| 88 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.79037354 |
| 89 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78248936 |
| 90 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.77439704 |
| 91 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.77074604 |
| 92 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.75795410 |
| 93 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.74491245 |
| 94 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.74363812 |
| 95 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.74293538 |
| 96 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.71084075 |
| 97 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.71064379 |
| 98 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.71047816 |
| 99 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.69959872 |
| 100 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.69948208 |
| 101 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.69710914 |
| 102 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.67812777 |
| 103 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.67328073 |
| 104 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.67328073 |
| 105 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.67244777 |
| 106 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.66848899 |
| 107 | CJUN_26792858_Chip-Seq_BT549_Human | 0.66750117 |
| 108 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.65670384 |
| 109 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.65035439 |
| 110 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.64822568 |
| 111 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.64758363 |
| 112 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.64441732 |
| 113 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.63298341 |
| 114 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.62897447 |
| 115 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.62194187 |
| 116 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.61609682 |
| 117 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.61468717 |
| 118 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.61288105 |
| 119 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.61205983 |
| 120 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.60632080 |
| 121 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.60262072 |
| 122 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.59889250 |
| 123 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.59660093 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 6.41087019 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 6.37565318 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.22352448 |
| 4 | MP0008875_abnormal_xenobiotic_pharmacok | 4.80901527 |
| 5 | MP0005365_abnormal_bile_salt | 4.78561146 |
| 6 | MP0009840_abnormal_foam_cell | 3.65261319 |
| 7 | MP0003191_abnormal_cellular_cholesterol | 3.39936747 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.32050047 |
| 9 | MP0003252_abnormal_bile_duct | 3.28931224 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 2.63776001 |
| 11 | MP0001666_abnormal_nutrient_absorption | 2.44886462 |
| 12 | MP0002138_abnormal_hepatobiliary_system | 2.28599167 |
| 13 | MP0005083_abnormal_biliary_tract | 2.27975942 |
| 14 | MP0009379_abnormal_foot_pigmentation | 2.20385322 |
| 15 | MP0010352_gastrointestinal_tract_polyps | 2.10385306 |
| 16 | MP0003183_abnormal_peptide_metabolism | 2.09909828 |
| 17 | MP0005332_abnormal_amino_acid | 2.08631633 |
| 18 | MP0002254_reproductive_system_inflammat | 1.94089980 |
| 19 | MP0000609_abnormal_liver_physiology | 1.89025973 |
| 20 | MP0004019_abnormal_vitamin_homeostasis | 1.86750861 |
| 21 | * MP0002118_abnormal_lipid_homeostasis | 1.82667832 |
| 22 | MP0010368_abnormal_lymphatic_system | 1.76326563 |
| 23 | MP0004147_increased_porphyrin_level | 1.75812158 |
| 24 | MP0003705_abnormal_hypodermis_morpholog | 1.72018933 |
| 25 | MP0005319_abnormal_enzyme/_coenzyme | 1.66673576 |
| 26 | MP0004782_abnormal_surfactant_physiolog | 1.66118918 |
| 27 | MP0005409_darkened_coat_color | 1.59334302 |
| 28 | MP0003724_increased_susceptibility_to | 1.57593608 |
| 29 | MP0003866_abnormal_defecation | 1.53108802 |
| 30 | MP0005501_abnormal_skin_physiology | 1.46662025 |
| 31 | MP0001664_abnormal_digestion | 1.41966592 |
| 32 | MP0005058_abnormal_lysosome_morphology | 1.40834953 |
| 33 | MP0000516_abnormal_urinary_system | 1.40215849 |
| 34 | MP0005367_renal/urinary_system_phenotyp | 1.40215849 |
| 35 | MP0009764_decreased_sensitivity_to | 1.39874475 |
| 36 | MP0003195_calcinosis | 1.37300748 |
| 37 | MP0001764_abnormal_homeostasis | 1.37107055 |
| 38 | MP0001765_abnormal_ion_homeostasis | 1.32244739 |
| 39 | MP0009643_abnormal_urine_homeostasis | 1.31996057 |
| 40 | MP0005464_abnormal_platelet_physiology | 1.29149597 |
| 41 | MP0003300_gastrointestinal_ulcer | 1.28908610 |
| 42 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.20907992 |
| 43 | MP0010678_abnormal_skin_adnexa | 1.19990088 |
| 44 | MP0002876_abnormal_thyroid_physiology | 1.19630678 |
| 45 | MP0003868_abnormal_feces_composition | 1.17643725 |
| 46 | MP0000477_abnormal_intestine_morphology | 1.14923725 |
| 47 | MP0005167_abnormal_blood-brain_barrier | 1.12288186 |
| 48 | MP0008469_abnormal_protein_level | 1.12146344 |
| 49 | MP0003075_altered_response_to | 1.12110920 |
| 50 | MP0003690_abnormal_glial_cell | 1.11187619 |
| 51 | MP0000604_amyloidosis | 1.09194254 |
| 52 | MP0002098_abnormal_vibrissa_morphology | 1.08448084 |
| 53 | MP0010234_abnormal_vibrissa_follicle | 1.05452387 |
| 54 | MP0003303_peritoneal_inflammation | 1.03099853 |
| 55 | MP0000598_abnormal_liver_morphology | 1.03014882 |
| 56 | MP0003186_abnormal_redox_activity | 1.00399257 |
| 57 | MP0006082_CNS_inflammation | 0.99261202 |
| 58 | MP0001835_abnormal_antigen_presentation | 0.98600712 |
| 59 | MP0004883_abnormal_blood_vessel | 0.98222453 |
| 60 | MP0003436_decreased_susceptibility_to | 0.97922493 |
| 61 | MP0000490_abnormal_crypts_of | 0.96418631 |
| 62 | MP0002132_abnormal_respiratory_system | 0.96249315 |
| 63 | MP0000537_abnormal_urethra_morphology | 0.95772074 |
| 64 | MP0001542_abnormal_bone_strength | 0.94778165 |
| 65 | MP0009763_increased_sensitivity_to | 0.93962674 |
| 66 | MP0004264_abnormal_extraembryonic_tissu | 0.93811740 |
| 67 | MP0004130_abnormal_muscle_cell | 0.92222243 |
| 68 | MP0001533_abnormal_skeleton_physiology | 0.92099445 |
| 69 | MP0005164_abnormal_response_to | 0.91557678 |
| 70 | MP0003329_amyloid_beta_deposits | 0.91167674 |
| 71 | MP0005670_abnormal_white_adipose | 0.89610858 |
| 72 | MP0005166_decreased_susceptibility_to | 0.89563116 |
| 73 | MP0000249_abnormal_blood_vessel | 0.88087795 |
| 74 | MP0000465_gastrointestinal_hemorrhage | 0.87450368 |
| 75 | MP0001851_eye_inflammation | 0.87047077 |
| 76 | MP0005023_abnormal_wound_healing | 0.87011138 |
| 77 | MP0001216_abnormal_epidermal_layer | 0.86623901 |
| 78 | MP0010386_abnormal_urinary_bladder | 0.85920916 |
| 79 | MP0003656_abnormal_erythrocyte_physiolo | 0.85888754 |
| 80 | MP0005451_abnormal_body_composition | 0.82952663 |
| 81 | MP0005165_increased_susceptibility_to | 0.82756550 |
| 82 | MP0009333_abnormal_splenocyte_physiolog | 0.82360101 |
| 83 | MP0003941_abnormal_skin_development | 0.81058078 |
| 84 | MP0001756_abnormal_urination | 0.80808287 |
| 85 | MP0009384_cardiac_valve_regurgitation | 0.79930960 |
| 86 | MP0005647_abnormal_sex_gland | 0.79583498 |
| 87 | MP0005376_homeostasis/metabolism_phenot | 0.79457556 |
| 88 | MP0000343_altered_response_to | 0.78081022 |
| 89 | MP0002419_abnormal_innate_immunity | 0.77950241 |
| 90 | * MP0009642_abnormal_blood_homeostasis | 0.77826331 |
| 91 | MP0009697_abnormal_copulation | 0.77541212 |
| 92 | MP0008438_abnormal_cutaneous_collagen | 0.77501455 |
| 93 | MP0001879_abnormal_lymphatic_vessel | 0.76518538 |
| 94 | MP0010155_abnormal_intestine_physiology | 0.76332748 |
| 95 | MP0005666_abnormal_adipose_tissue | 0.75560531 |
| 96 | MP0003566_abnormal_cell_adhesion | 0.74379182 |
| 97 | MP0008004_abnormal_stomach_pH | 0.73215556 |
| 98 | MP0004272_abnormal_basement_membrane | 0.72190028 |
| 99 | MP0001845_abnormal_inflammatory_respons | 0.72154358 |
| 100 | MP0005334_abnormal_fat_pad | 0.71571470 |
| 101 | MP0001873_stomach_inflammation | 0.71128837 |
| 102 | MP0005448_abnormal_energy_balance | 0.70895552 |
| 103 | MP0004185_abnormal_adipocyte_glucose | 0.70129270 |
| 104 | MP0005636_abnormal_mineral_homeostasis | 0.69287466 |
| 105 | MP0002971_abnormal_brown_adipose | 0.68930459 |
| 106 | MP0009053_abnormal_anal_canal | 0.68855586 |
| 107 | MP0003828_pulmonary_edema | 0.68385816 |
| 108 | MP0002136_abnormal_kidney_physiology | 0.68127530 |
| 109 | MP0005275_abnormal_skin_tensile | 0.67676085 |
| 110 | MP0003638_abnormal_response/metabolism_ | 0.67608117 |
| 111 | MP0000230_abnormal_systemic_arterial | 0.66934946 |
| 112 | MP0005408_hypopigmentation | 0.66434712 |
| 113 | MP0004043_abnormal_pH_regulation | 0.65219553 |
| 114 | MP0002009_preneoplasia | 0.64981993 |
| 115 | MP0002998_abnormal_bone_remodeling | 0.64918817 |
| 116 | MP0005381_digestive/alimentary_phenotyp | 0.64652827 |
| 117 | MP0000377_abnormal_hair_follicle | 0.64520240 |
| 118 | MP0001853_heart_inflammation | 0.63643270 |
| 119 | MP0009115_abnormal_fat_cell | 0.62403588 |
| 120 | MP0009765_abnormal_xenobiotic_induced | 0.62337122 |
| 121 | MP0005025_abnormal_response_to | 0.62051777 |
| 122 | MP0001958_emphysema | 0.60240511 |
| 123 | MP0005535_abnormal_body_temperature | 0.60162762 |
| 124 | MP0000383_abnormal_hair_follicle | 0.59840581 |
| 125 | MP0008873_increased_physiological_sensi | 0.59703160 |
| 126 | MP0001986_abnormal_taste_sensitivity | 0.59424948 |
| 127 | MP0001661_extended_life_span | 0.59296014 |
| 128 | MP0002166_altered_tumor_susceptibility | 0.58271123 |
| 129 | MP0002060_abnormal_skin_morphology | 0.56980733 |
| 130 | MP0003453_abnormal_keratinocyte_physiol | 0.56666953 |
| 131 | MP0000685_abnormal_immune_system | 0.55328885 |
| 132 | MP0002295_abnormal_pulmonary_circulatio | 0.54924317 |
| 133 | MP0009785_altered_susceptibility_to | 0.54714420 |
| 134 | MP0001663_abnormal_digestive_system | 0.54576110 |
| 135 | MP0002796_impaired_skin_barrier | 0.54251883 |
| 136 | MP0003011_delayed_dark_adaptation | 0.52387970 |
| 137 | MP0004947_skin_inflammation | 0.51851431 |
| 138 | MP0000767_abnormal_smooth_muscle | 0.51654928 |
| 139 | MP0000538_abnormal_urinary_bladder | 0.51585479 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.71096950 |
| 2 | Complement deficiency (HP:0004431) | 5.97264024 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 5.72845284 |
| 4 | Xanthomatosis (HP:0000991) | 5.41051332 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.33552864 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.24938108 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.03873870 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 4.97142012 |
| 9 | Joint hemorrhage (HP:0005261) | 4.86466548 |
| 10 | Systemic lupus erythematosus (HP:0002725) | 4.80652409 |
| 11 | Abnormality of complement system (HP:0005339) | 4.55412314 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 4.54243921 |
| 13 | Hyperactive renin-angiotensin system (HP:0000841) | 4.00239423 |
| 14 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.99901833 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 3.86181201 |
| 16 | Hypolipoproteinemia (HP:0010981) | 3.85992401 |
| 17 | Decreased circulating renin level (HP:0003351) | 3.70603724 |
| 18 | Epidermoid cyst (HP:0200040) | 3.70522345 |
| 19 | Glomerulonephritis (HP:0000099) | 3.69161328 |
| 20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.66909994 |
| 21 | Fat malabsorption (HP:0002630) | 3.60269535 |
| 22 | Hyperammonemia (HP:0001987) | 3.48575695 |
| 23 | Hypoalphalipoproteinemia (HP:0003233) | 3.40797553 |
| 24 | Abnormality of the intrinsic pathway (HP:0010989) | 3.37985606 |
| 25 | Hypercholesterolemia (HP:0003124) | 3.34437456 |
| 26 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.32712830 |
| 27 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.21782087 |
| 28 | Myocardial infarction (HP:0001658) | 3.21377222 |
| 29 | Hyperglycinuria (HP:0003108) | 3.18100392 |
| 30 | Alkalosis (HP:0001948) | 3.15205264 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.12015957 |
| 32 | Chronic diarrhea (HP:0002028) | 3.11733913 |
| 33 | Polycythemia (HP:0001901) | 3.07155334 |
| 34 | Ketosis (HP:0001946) | 3.05487391 |
| 35 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.00288649 |
| 36 | Esophageal varix (HP:0002040) | 2.97254043 |
| 37 | Widely patent fontanelles and sutures (HP:0004492) | 2.96453579 |
| 38 | Abnormality of glycine metabolism (HP:0010895) | 2.95876932 |
| 39 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.95876932 |
| 40 | Vascular calcification (HP:0004934) | 2.94815581 |
| 41 | Hyperaldosteronism (HP:0000859) | 2.89931665 |
| 42 | Abnormality of renin-angiotensin system (HP:0000847) | 2.87192678 |
| 43 | Amyloidosis (HP:0011034) | 2.85409002 |
| 44 | Abnormality of methionine metabolism (HP:0010901) | 2.84179290 |
| 45 | Spontaneous hematomas (HP:0007420) | 2.83856282 |
| 46 | Hyperglycinemia (HP:0002154) | 2.83808006 |
| 47 | Abnormality of vitamin metabolism (HP:0100508) | 2.80329800 |
| 48 | Hypoglycemic coma (HP:0001325) | 2.79333588 |
| 49 | Nephritis (HP:0000123) | 2.74141798 |
| 50 | Flat acetabular roof (HP:0003180) | 2.72251225 |
| 51 | Renal salt wasting (HP:0000127) | 2.70308358 |
| 52 | Cardiovascular calcification (HP:0011915) | 2.69213795 |
| 53 | Focal segmental glomerulosclerosis (HP:0000097) | 2.67105858 |
| 54 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.67035538 |
| 55 | Steatorrhea (HP:0002570) | 2.64818146 |
| 56 | Metabolic alkalosis (HP:0200114) | 2.64146458 |
| 57 | Ileus (HP:0002595) | 2.61074509 |
| 58 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.60206315 |
| 59 | Proximal tubulopathy (HP:0000114) | 2.59750692 |
| 60 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.59404048 |
| 61 | Hyperbilirubinemia (HP:0002904) | 2.56708644 |
| 62 | Abnormality of proline metabolism (HP:0010907) | 2.53933066 |
| 63 | Hydroxyprolinuria (HP:0003080) | 2.53933066 |
| 64 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.50491989 |
| 65 | Hematochezia (HP:0002573) | 2.49827347 |
| 66 | Hepatocellular carcinoma (HP:0001402) | 2.49598240 |
| 67 | Abdominal distention (HP:0003270) | 2.49018929 |
| 68 | Abnormality of nucleobase metabolism (HP:0010932) | 2.47963883 |
| 69 | Right ventricular cardiomyopathy (HP:0011663) | 2.46043423 |
| 70 | Menorrhagia (HP:0000132) | 2.45762837 |
| 71 | Pigmentary retinal degeneration (HP:0001146) | 2.44595770 |
| 72 | Abnormality of purine metabolism (HP:0004352) | 2.42243801 |
| 73 | Nausea (HP:0002018) | 2.39373018 |
| 74 | Malnutrition (HP:0004395) | 2.38012872 |
| 75 | Abnormality of vitamin B metabolism (HP:0004340) | 2.37843238 |
| 76 | Thin bony cortex (HP:0002753) | 2.33571902 |
| 77 | Glomerulosclerosis (HP:0000096) | 2.32457530 |
| 78 | Spontaneous abortion (HP:0005268) | 2.32365864 |
| 79 | Thrombophlebitis (HP:0004418) | 2.31966759 |
| 80 | Pulmonary embolism (HP:0002204) | 2.31804639 |
| 81 | Facial shape deformation (HP:0011334) | 2.29766967 |
| 82 | Potter facies (HP:0002009) | 2.29766967 |
| 83 | Abnormality of urine glucose concentration (HP:0011016) | 2.28749113 |
| 84 | Glycosuria (HP:0003076) | 2.28749113 |
| 85 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.26219880 |
| 86 | Skin nodule (HP:0200036) | 2.26100084 |
| 87 | Conjunctival telangiectasia (HP:0000524) | 2.21732154 |
| 88 | Pancreatitis (HP:0001733) | 2.20084829 |
| 89 | Mitral stenosis (HP:0001718) | 2.20078787 |
| 90 | Wide cranial sutures (HP:0010537) | 2.18528702 |
| 91 | Confusion (HP:0001289) | 2.14982796 |
| 92 | Interstitial pulmonary disease (HP:0006530) | 2.14802401 |
| 93 | Metabolic acidosis (HP:0001942) | 2.13244171 |
| 94 | Gingival bleeding (HP:0000225) | 2.12312583 |
| 95 | Petechiae (HP:0000967) | 2.11592200 |
| 96 | Hemorrhage of the eye (HP:0011885) | 2.11294043 |
| 97 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.09890471 |
| 98 | Villous atrophy (HP:0011473) | 2.09890471 |
| 99 | Abnormal tarsal ossification (HP:0008369) | 2.08685916 |
| 100 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.08353241 |
| 101 | Mucopolysacchariduria (HP:0008155) | 2.08353241 |
| 102 | Ketoacidosis (HP:0001993) | 2.06597238 |
| 103 | Abnormality of the nasal mucosa (HP:0000433) | 2.06039214 |
| 104 | Hypochromic microcytic anemia (HP:0004840) | 2.04207393 |
| 105 | Aortic aneurysm (HP:0004942) | 2.02971146 |
| 106 | Purpura (HP:0000979) | 2.00465058 |
| 107 | Nephrolithiasis (HP:0000787) | 1.99739278 |
| 108 | Spastic diplegia (HP:0001264) | 1.99566478 |
| 109 | Abnormal cartilage morphology (HP:0002763) | 1.99308723 |
| 110 | Poikilocytosis (HP:0004447) | 1.99197952 |
| 111 | Rickets (HP:0002748) | 1.98297605 |
| 112 | Acanthocytosis (HP:0001927) | 1.96626618 |
| 113 | Hypotension (HP:0002615) | 1.95205009 |
| 114 | Delayed CNS myelination (HP:0002188) | 1.94881960 |
| 115 | Dysostosis multiplex (HP:0000943) | 1.94219649 |
| 116 | Abnormal glucose tolerance (HP:0001952) | 1.93502099 |
| 117 | Abnormal platelet function (HP:0011869) | 1.92301421 |
| 118 | Impaired platelet aggregation (HP:0003540) | 1.92301421 |
| 119 | Epistaxis (HP:0000421) | 1.92129701 |
| 120 | Hypophosphatemia (HP:0002148) | 1.91422131 |
| 121 | Vacuolated lymphocytes (HP:0001922) | 1.91355590 |
| 122 | Increased mean platelet volume (HP:0011877) | 1.91176116 |
| 123 | Pustule (HP:0200039) | 1.88730369 |
| 124 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.88078781 |
| 125 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.88078781 |
| 126 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.88078781 |
| 127 | Dehydration (HP:0001944) | 1.87445280 |
| 128 | Abnormal gallbladder physiology (HP:0012438) | 1.86722669 |
| 129 | Cholecystitis (HP:0001082) | 1.86722669 |
| 130 | Hypokalemia (HP:0002900) | 1.86556418 |
| 131 | Axonal loss (HP:0003447) | 1.86442102 |
| 132 | Abnormality of chloride homeostasis (HP:0011422) | 1.84849566 |
| 133 | Congenital sensorineural hearing impairment (HP:0008527) | 1.84100795 |
| 134 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.83409505 |
| 135 | Renal tubular acidosis (HP:0001947) | 1.82816717 |
| 136 | Dicarboxylic aciduria (HP:0003215) | 1.82798137 |
| 137 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.82798137 |
| 138 | Stroke (HP:0001297) | 1.82545801 |
| 139 | Sensorimotor neuropathy (HP:0007141) | 1.82434530 |
| 140 | Visceral angiomatosis (HP:0100761) | 1.81967310 |
| 141 | Abnormality of serum amino acid levels (HP:0003112) | 1.81509624 |
| 142 | Abnormal gallbladder morphology (HP:0012437) | 1.81150203 |
| 143 | Abnormal platelet volume (HP:0011876) | 1.81089880 |
| 144 | Enlarged epiphyses (HP:0010580) | 1.80642153 |
| 145 | Hyperuricemia (HP:0002149) | 1.79614830 |
| 146 | Increased purine levels (HP:0004368) | 1.79614830 |
| 147 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.78579748 |
| 148 | Prolonged bleeding time (HP:0003010) | 1.77901359 |
| 149 | Pili torti (HP:0003777) | 1.77820540 |
| 150 | Curly hair (HP:0002212) | 1.74789301 |
| 151 | Abnormal hair laboratory examination (HP:0003328) | 1.70805716 |
| 152 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.70474831 |
| 153 | * Joint swelling (HP:0001386) | 1.69078306 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 4.69921971 |
| 2 | TGFBR2 | 4.24412222 |
| 3 | ERN1 | 3.65164485 |
| 4 | PKN2 | 3.57932771 |
| 5 | EPHA2 | 3.37578076 |
| 6 | BCKDK | 3.05252059 |
| 7 | TAOK3 | 2.97828702 |
| 8 | TRIB3 | 2.73733210 |
| 9 | AKT3 | 2.73383765 |
| 10 | TIE1 | 2.66115545 |
| 11 | FGFR4 | 2.65482586 |
| 12 | FRK | 2.56935627 |
| 13 | TYK2 | 2.54111155 |
| 14 | SIK1 | 2.39291868 |
| 15 | EPHB1 | 2.38232323 |
| 16 | PTK6 | 2.21739634 |
| 17 | MYLK | 2.11587051 |
| 18 | STK39 | 1.98098697 |
| 19 | MST4 | 1.94075185 |
| 20 | MST1R | 1.84730334 |
| 21 | RIPK1 | 1.75521132 |
| 22 | MAP3K12 | 1.71869055 |
| 23 | RIPK4 | 1.69065328 |
| 24 | PIK3CG | 1.65801062 |
| 25 | MAP3K3 | 1.49600930 |
| 26 | MAPK15 | 1.47628686 |
| 27 | BMPR2 | 1.43627938 |
| 28 | MAP2K3 | 1.39368914 |
| 29 | STK10 | 1.33946256 |
| 30 | PDK2 | 1.29434697 |
| 31 | MAP2K2 | 1.27751291 |
| 32 | JAK1 | 1.26988247 |
| 33 | FLT3 | 1.26348935 |
| 34 | CSK | 1.26149248 |
| 35 | NEK9 | 1.24010158 |
| 36 | GRK6 | 1.23872731 |
| 37 | JAK2 | 1.20976859 |
| 38 | TBK1 | 1.20544249 |
| 39 | INSRR | 1.19214240 |
| 40 | PRPF4B | 1.17897056 |
| 41 | FGFR2 | 1.17082473 |
| 42 | MAP3K2 | 1.16692857 |
| 43 | BLK | 1.16681384 |
| 44 | CAMK1D | 1.16614422 |
| 45 | NLK | 1.15407785 |
| 46 | MAP3K7 | 1.15067241 |
| 47 | STK24 | 1.14989357 |
| 48 | PAK4 | 1.13851754 |
| 49 | OXSR1 | 1.10860585 |
| 50 | CDK6 | 1.07823117 |
| 51 | LRRK2 | 1.07287639 |
| 52 | CSF1R | 1.05948726 |
| 53 | MAPK11 | 1.03627425 |
| 54 | TTN | 0.98318108 |
| 55 | EEF2K | 0.98106012 |
| 56 | EPHA3 | 0.95141729 |
| 57 | GRK7 | 0.92945969 |
| 58 | TEC | 0.92581730 |
| 59 | MAP3K1 | 0.92271428 |
| 60 | MAPK4 | 0.89820076 |
| 61 | LMTK2 | 0.89314299 |
| 62 | PRKAA2 | 0.85387867 |
| 63 | DDR2 | 0.83753286 |
| 64 | GRK1 | 0.83590409 |
| 65 | BTK | 0.83078818 |
| 66 | ERBB4 | 0.79618488 |
| 67 | ITK | 0.78385338 |
| 68 | ERBB3 | 0.78296914 |
| 69 | ZAP70 | 0.78171425 |
| 70 | GSK3A | 0.77996370 |
| 71 | TGFBR1 | 0.76978170 |
| 72 | KDR | 0.76060448 |
| 73 | FGFR3 | 0.73159606 |
| 74 | TESK2 | 0.72545895 |
| 75 | LATS1 | 0.72138485 |
| 76 | MAP2K6 | 0.68892091 |
| 77 | DAPK2 | 0.68785899 |
| 78 | PDPK1 | 0.67585727 |
| 79 | MAP3K14 | 0.67057041 |
| 80 | IRAK3 | 0.66885858 |
| 81 | IRAK4 | 0.66794560 |
| 82 | KIT | 0.65349348 |
| 83 | PTK2 | 0.65165343 |
| 84 | IKBKE | 0.64915405 |
| 85 | PAK2 | 0.63672296 |
| 86 | EPHB2 | 0.63254510 |
| 87 | SCYL2 | 0.63195134 |
| 88 | MAP3K10 | 0.62843189 |
| 89 | RPS6KA2 | 0.61721405 |
| 90 | PDGFRB | 0.60753500 |
| 91 | PRKG2 | 0.59333807 |
| 92 | TESK1 | 0.57436829 |
| 93 | MAPKAPK3 | 0.54788456 |
| 94 | RET | 0.54630193 |
| 95 | PRKACG | 0.52302956 |
| 96 | BMX | 0.52254369 |
| 97 | PDK1 | 0.51435843 |
| 98 | MAP2K1 | 0.51362603 |
| 99 | PIK3CA | 0.49765546 |
| 100 | MAPK12 | 0.49365887 |
| 101 | YES1 | 0.49348673 |
| 102 | RPS6KL1 | 0.49187503 |
| 103 | RPS6KC1 | 0.49187503 |
| 104 | CAMK1G | 0.48328762 |
| 105 | MAP2K4 | 0.45330405 |
| 106 | MAP4K1 | 0.45290549 |
| 107 | RPS6KB2 | 0.44800470 |
| 108 | RPS6KA6 | 0.44142276 |
| 109 | MET | 0.43873546 |
| 110 | DYRK1B | 0.43695413 |
| 111 | IGF1R | 0.43693831 |
| 112 | KSR2 | 0.43298391 |
| 113 | ABL2 | 0.42069274 |
| 114 | MAP3K6 | 0.42050035 |
| 115 | MATK | 0.41733126 |
| 116 | MAP3K11 | 0.41544205 |
| 117 | SIK2 | 0.41177593 |
| 118 | MAPK7 | 0.41054403 |
| 119 | PDGFRA | 0.40341081 |
| 120 | ERBB2 | 0.40313958 |
| 121 | TRPM7 | 0.40000672 |
| 122 | PRKD1 | 0.39935043 |
| 123 | FER | 0.38991312 |
| 124 | DMPK | 0.38823888 |
| 125 | SGK3 | 0.38509129 |
| 126 | EGFR | 0.38265071 |
| 127 | STK3 | 0.38092785 |
| 128 | PIM1 | 0.37903985 |
| 129 | MELK | 0.37820190 |
| 130 | CDC42BPA | 0.35242399 |
| 131 | SRC | 0.35114428 |
| 132 | ILK | 0.33524497 |
| 133 | JAK3 | 0.32323421 |
| 134 | BCR | 0.31019356 |
| 135 | PRKCA | 0.28129854 |
| 136 | PRKCD | 0.27466080 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.78440746 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.56189884 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.14107853 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.82860984 |
| 5 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.64021504 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.62471627 |
| 7 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.61232133 |
| 8 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.50592277 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.47821204 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.47112254 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.37628343 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.33984563 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.30339830 |
| 14 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.28631656 |
| 15 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.20889158 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.09998070 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 2.04424457 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.03500612 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.93764310 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.92011436 |
| 21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.91712858 |
| 22 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.78041584 |
| 23 | Peroxisome_Homo sapiens_hsa04146 | 1.77335800 |
| 24 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.76250821 |
| 25 | Retinol metabolism_Homo sapiens_hsa00830 | 1.74152933 |
| 26 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.67621085 |
| 27 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.61759597 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.61607243 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.60984051 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.58318138 |
| 31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.55410912 |
| 32 | Bile secretion_Homo sapiens_hsa04976 | 1.54836689 |
| 33 | ABC transporters_Homo sapiens_hsa02010 | 1.51603250 |
| 34 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.48646164 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.46368390 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.38633809 |
| 37 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.27335589 |
| 38 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.11090010 |
| 39 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.09379276 |
| 40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.08730083 |
| 41 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.08200118 |
| 42 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.07828875 |
| 43 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.07726538 |
| 44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.05230573 |
| 45 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.03685509 |
| 46 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.02941837 |
| 47 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.02198905 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 0.96058131 |
| 49 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.89472158 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.88878158 |
| 51 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.87767757 |
| 52 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.87525507 |
| 53 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.86350754 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.85048258 |
| 55 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.84917986 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.84206883 |
| 57 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.83960087 |
| 58 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.81772456 |
| 59 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.81532938 |
| 60 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.79380200 |
| 61 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.70255087 |
| 62 | Lysine degradation_Homo sapiens_hsa00310 | 0.70082401 |
| 63 | Sulfur relay system_Homo sapiens_hsa04122 | 0.68024257 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.66950346 |
| 65 | Galactose metabolism_Homo sapiens_hsa00052 | 0.66103377 |
| 66 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.65435108 |
| 67 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.63026003 |
| 68 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.60335762 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.59829321 |
| 70 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.59711179 |
| 71 | Other glycan degradation_Homo sapiens_hsa00511 | 0.53394172 |
| 72 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.52130485 |
| 73 | Prion diseases_Homo sapiens_hsa05020 | 0.50426209 |
| 74 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.45694541 |
| 75 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.45690778 |
| 76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.43849935 |
| 77 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.43302207 |
| 78 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.42511665 |
| 79 | Insulin resistance_Homo sapiens_hsa04931 | 0.40853652 |
| 80 | Lysosome_Homo sapiens_hsa04142 | 0.40376340 |
| 81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35767758 |
| 82 | Pertussis_Homo sapiens_hsa05133 | 0.35309600 |
| 83 | Platelet activation_Homo sapiens_hsa04611 | 0.33022184 |
| 84 | Asthma_Homo sapiens_hsa05310 | 0.27626072 |
| 85 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.27398725 |
| 86 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27324688 |
| 87 | Metabolic pathways_Homo sapiens_hsa01100 | 0.26956198 |
| 88 | Mineral absorption_Homo sapiens_hsa04978 | 0.22876333 |
| 89 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.20883826 |
| 90 | Renin secretion_Homo sapiens_hsa04924 | 0.20754292 |
| 91 | Thyroid cancer_Homo sapiens_hsa05216 | 0.18123406 |
| 92 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.17880714 |
| 93 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.17853587 |
| 94 | Leishmaniasis_Homo sapiens_hsa05140 | 0.17759256 |
| 95 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.16757046 |
| 96 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.16500370 |
| 97 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.16362179 |
| 98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.16354712 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15907284 |
| 100 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.15823324 |
| 101 | Tight junction_Homo sapiens_hsa04530 | 0.15314872 |
| 102 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.13203579 |
| 103 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.12541060 |
| 104 | Hepatitis C_Homo sapiens_hsa05160 | 0.11192499 |
| 105 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.09115069 |
| 106 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.08063395 |
| 107 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.07490093 |
| 108 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.07024684 |
| 109 | Amoebiasis_Homo sapiens_hsa05146 | 0.06689561 |
| 110 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.06211775 |
| 111 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.05450714 |
| 112 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.05017409 |
| 113 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.04290927 |
| 114 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.02627081 |
| 115 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.02396702 |
| 116 | Legionellosis_Homo sapiens_hsa05134 | 0.01619290 |
| 117 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.01268774 |
| 118 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01178532 |
| 119 | Malaria_Homo sapiens_hsa05144 | 0.01164500 |
| 120 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0015793 |

